September 2023 in “Journal of the American Academy of Dermatology” In this study, researchers found that Hispanic/Latino patients in the USA were diagnosed with melanoma at younger ages and at more advanced stages than non-Hispanic/Latino Whites, which contributed to lower melanoma-specific survival rates among Hispanics/Latinos.
27 citations
,
April 2019 in “Journal of The American Academy of Dermatology” This study found that melanoma on the posterior scalp is associated with worse survival compared to other body sites, while sun-exposed areas showed better survival outcomes.
January 2026 in “EJC Skin Cancer” In this study, researchers detailed the sociodemographic, clinicopathological traits, and survival outcomes of untreated, resectable stage I–III melanoma patients in Serbia, focusing on recurrence rates and survival metrics segmented by AJCC sub-stage.
1 citations
,
December 2023 in “Journal of Clinical Medicine” This study observed that scalp melanomas had worse outcomes than non-scalp head and neck melanomas, with a higher risk of recurrence and melanoma-specific death.
3 citations
,
October 2018 in “Journal of Mind and Medical Sciences” This study highlights that biological therapy, which stimulates the immune system through various methods like cytokine injections and immune checkpoint inhibition, shows promise for treating melanoma based on laboratory and clinical studies.